Sono-Tek Corp
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.7% | +0.6% | +9.7% | +3.6% | +20.8% | +11.4% | +7.3% | +14.5% | +14.7% | +1.2% | +12.9% | |
| – | +1.5% | +4.3% | +10.9% | +3.1% | +26.6% | +16.1% | +10.1% | +14.3% | +13.1% | +1.3% | +20.2% | |
| – | -6.8% | +7.1% | -21.1% | +55.9% | +16.4% | +11.6% | +18.5% | -30.7% | -36.4% | +143.7% | +41.1% | |
| – | -3.1% | +20.0% | +31.1% | -14.2% | +43.0% | +9.8% | +23.8% | +6.9% | +3.5% | +0.7% | +24.1% | |
| – | +18.0% | -5.3% | -32.7% | +80.4% | -33.5% | +89.1% | -37.8% | +49.6% | -10.0% | +59.6% | +42.7% | |
| – | -5.5% | -31.1% | +1.0% | +22.4% | +43.7% | +9.6% | -9.1% | +36.6% | +61.0% | -14.3% | -12.3% | |
| – | +0.0% | +999.7% | -7.0% | +9.0% | +11.9% | -6.9% | -3.1% | -91.1% | – | – | – | |
| – | -0.8% | -11.9% | -10.9% | -10.0% | -13.5% | -10.2% | -20.4% | -24.7% | -16.8% | -21.4% | -20.3% | |
| – | -12.9% | -6.3% | +20.4% | +6.8% | +37.2% | +10.3% | -29.0% | +42.6% | +23.7% | -18.0% | +18.3% | |
| – | -22.3% | -12.4% | +47.1% | +19.1% | +64.4% | +2.3% | -12.9% | +46.9% | +21.4% | -17.2% | +20.1% | |
| – | -9.4% | +4.4% | +4.3% | +4.3% | +4.2% | – | – | – | – | – | – | |
| – | -18.7% | -29.2% | +94.0% | -10.3% | +14.2% | +93.6% | -47.1% | +18.5% | +29.5% | -18.1% | +20.9% | |
| – | -10.9% | -12.7% | -15.2% | -18.7% | -24.0% | +86.2% | – | – | – | – | – | |
| – | +7.3% | +3.3% | +5.9% | +2.3% | +14.0% | +11.9% | +25.5% | +6.5% | +11.2% | +9.3% | +11.1% | |
| – | – | – | – | – | – | +183.6% | +146.9% | +14.9% | +29.4% | +20.1% | +23.7% | |
| – | +1.2% | -0.1% | +0.5% | +0.8% | +0.9% | +2.0% | -0.3% | +0.9% | +0.0% | 0.0% | -0.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.